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Tuberculosis (TB) surveillance commonly focuses on 
pulmonary (PTB) where the main organ affected is 
the lung. This might lead to underestimate extrapul-
monary TB (EPTB) forms, where in addition to the lung 
other sites are affected by TB. In Germany, TB notifi-
cation data provide the main site and the secondary 
site of disease. To gain an overview of all the differ-
ent EPTB forms, we analysed German TB notification 
data between 2002 and 2009 using information on 
both main and secondary disease site to describe all 
individual EPTB forms. Further, we assessed factors 
associated with meningitis using multivariable logis-
tic regression. Solely analysing the main site of dis-
ease, lead to one third of EPTB manifestations being 
overlooked. Case characteristics varied substantially 
across individual extrapulmonary forms. Of 46,349 
TB patients, 422 (0.9%) had meningitis as main or 
secondary site. Of those, 105 (25%) of the 415 with 
available information had died. Multivariable analy-
sis showed that meningitis was more likely in children 
younger than five years and between five and nine 
years-old (odds ratio (OR): 4.90; 95% confidence inter-
val (CI): 3.40–7.07 and OR: 2.65; 95% CI: 1.40–5.00), 
in females (OR: 1.42; 95% CI: 1.17–1.73), and in those 
born in the World Health Organization (WHO) regions 
of south-east Asia (OR: 2.38; 95% CI: 1.66–3.43) and 
eastern Mediterranean (OR: 1.51; 95% CI: 1.02–2.23). 
Overall, EPTB manifestations, including meningitis, 
which is often fatal, were underestimated by routine 
analysis. We thus recommend using all information 
on disease manifestation generated by surveillance 
to monitor severe forms and to transfer the gained 
knowledge to TB case management where awareness 
of EPTB is most important.
Introduction 
Global tuberculosis (TB) control focuses on pulmonary 
tuberculosis (PTB) to prevent transmission and reduce 
the number of new cases. Thus, in surveillance, TB 
cases are classified as pulmonary TB whenever lungs 
are involved, irrespective of any additional involvement 
of other organs [1]. However, extrapulmonary TB (EPTB), 
a collective term for diverse manifestations affecting 
any other anatomic site than the lung parenchyma and 
the tracheobronchial tree, substantially contributes to 
the TB burden. In the European Union and European 
Economic Area (EU/EEA), 22% of TB patients notified in 
2010 only had extrapulmonary manifestations [2]. EPTB 
is more common in immunocompromised individuals, 
especially people living with human immunodeficiency 
virus (HIV) [3-7], but also females and different ethnic 
groups [3,5-10]; for example, in the United Kingdom 
(UK) all non-white ethnic groups were associated with 
EPTB [8]. Socio-behavioural factors including smoking 
and alcohol abuse, in contrast, were associated with 
pulmonary manifestation [6,7,11-13]. 
Some EPTB forms, such as meningitis cause severe 
disease. Reported case fatality ranges from 20 to 69% 
[14] in different settings worldwide with up to half of 
surviving patients presenting with irreversible seque-
lae, including paraplegia, blindness, motor and cogni-
tive deficits [15-19]. Prognosis is largely influenced by 
early diagnosis and adequate treatment [4,17-19]. 
Meningitis TB most commonly occurs in infants and 
toddlers, mainly within three months after infection 
[3,20]. Its development may be influenced by genetic 
factors, differing across ethnic groups and certain 
strains of Mycobacterium tuberculosis complex [7,21]. 
Further, vitamin D deficiencies [22] and underlying con-
ditions influencing immunocompetency, including HIV 
infection [13,19,21,23] diabetes mellitus, malignancy 
and recent corticosteroid treatment, as well as alco-
hol abuse (in adults), have been described as risk fac-
tors for meningitis TB. Bacillus Calmette–Guérin (BCG) 
vaccines were reported to have a preventive effect in 
young children (30–82%) [24]. 
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In 2010, Germany, a low incidence country for TB (5.3 
cases per 100,000 population in 2010), reported that 
21% of patients had exclusively EPTB [25]. National 
TB surveillance captures disease manifestations as 
main and secondary site of disease (whereby only up 
to two sites can be recorded) and classifies extrapul-
monary forms into 11 sites as recommended by the 
World Health Organization (WHO): intrathoracic lymph 
nodes (LN), extrathoracic LN, pleura, genitourinary 
tract, abdomen, spine, bone and joints, meninges, 
other central nervous system (CNS), disseminated TB 
and any other organ [1]. Lungs, when affected by TB, 
can only be recorded as the main site of disease. If two 
different extrapulmonary sites are affected, physicians 
are asked to classify the more severely affected one 
as main site of disease. In line with other countries, 
surveillance data analyses and reporting focus on the 
main site of disease (privileging PTB). This may lead to 
underestimate EPTB manifestations overall, as well as 
EPTB forms causing severe disease such as meningitis 
TB. 
We conducted a study to (i) estimate the frequency of 
all individual EPTB forms, irrespective of the classifi-
cation as main or secondary site, (ii) describe demo-
graphic and clinical characteristics of patients affected 
by specific extrapulmonary sites of disease and (iii) 
identify factors associated with meningitis TB. 
Methods
Data source
We used case-based TB surveillance data from Germany 
between 2002 and 2009, electronically reported to the 
Robert Koch Institute (RKI) until 1 August 2010, and 
population data from the Federal Statistical Office to 
calculate incidences [26]. Surveillance defines active 
TB cases based on clinical diagnosis and the indica-
tion of a full-course of anti-TB treatment regimen with 
or without bacteriological confirmation or known epi-
demiological link to another confirmed case [27]. The 
notification system, case definitions and diagnostic 
procedures have remained largely the same over the 
investigation period. This is as well reflected by the 
stable proportion of bacteriologically-confirmed cases 
(72% to 75%) from 2002 to 2009.
Data analysis
We grouped cases into three categories: PTB only, both 
PTB and EPTB, and EPTB only (Figure 1), and calculated 
mean annual incidences (cases/100,000 populations). 
Further, we compared the proportions of these three 
groups in 2002 to those in 2009. 
We calculated the frequency of all 11 EPTB sites (i) 
using information regarding the main site of disease 
only and (ii) combining information from main and sec-
ondary sites of disease and compared the number of 
EPTB affected sites detected using either classifica-
tions. As up to two different disease sites per patient 
can be recorded, the same patient may belong to two 
different disease manifestation groups. 
To identify characteristics of patients affected by spe-
cific extrapulmonary manifestations, we tabulated 
demographic (i.e. age, sex, country of birth (foreign 
vs. German)) and clinical information (i.e. hospitali-
sation, duration of hospitalisation (in days) and case 
fatality ratio (CFR)) by site of disease. We presented 
proportions for categorical variables and median and 
interquartile-ranges (IQRs) for continuous variables. 
We excluded implausible values (e.g. negative values) 
in the duration of hospitalisation from the analysis.
To identify factors associated with meningitis TB, we 
compared meningitis (both as main and as secondary 
site) with non-meningitis TB cases in terms of possible 
exposures using the chi-squared test, odds ratios (OR), 
95% confidence intervals (CI) and two-sided p-values. 
Exposures examined included age, sex, country of 
birth, as well as being a new case, i.e. not previously 
treated. We grouped countries of birth into Germany, 
Figure 1
Overview of the notified tuberculosis patients and 
investigated groups, Germany, 2002–2009 (n=46,730)
Number of eligible TB 





Meningitis   422 
46,349 
Number of TB 
cases without  
information on the  
site of disease  
Total number of cases 
with  extrapulmonary TB: 
14,087 
Total number of cases  with 
pulmonary TB: 36,359 
Pulmonary and 
extrapulmonary   
4,097 
Exclusively 
extrapulmonary   9,990a
Exclusively 




notified TB cases 
TB: tuberculosis.
a 28 cases with no information on the main site of disease but 
available information on the secondary site are included in the 
exclusively extrapulmonary TB cases (n=9,990) presented in this 
flow chart.
3www.eurosurveillance.org
Turkey, Newly Independent States of the former Soviet 
Union (NIS), other countries of the WHO European 
region, as well as other WHO regions. We considered 
four age groups (individuals younger than 5 years, 5 
to 9 years, 10 to 14 years and 15 years or older). We 
included variables associated at p=0.2 in the univari-
able analysis in a multivariable logistic regression 
analysis using forward selection. We tested pairwise 
interactions of independent variables at each step 
and only included them when the likelihood ratio test 
pointed to an improvement of the model with a p-value 
less than 0.05. 
We analysed data using Excel (version 11, Microsoft 
Corporation Redmond, Washington, USA) and Stata 
(version 12.1, StataCorp LP, TX, USA) software.
Results
Study population
From 2002 to 2009, a total of 46,730 TB patients were 
reported in Germany (mean annual incidence of 6.3 
cases per 100,000 population). Of the 46,349 patients 
with information on the anatomic site of disease, 
32,262 (70%) had exclusively PTB, 4,097 (8.8%) had 
both PTB and EPTB and 9,990 (22%) had EPTB only 
(Figure 1). The TB incidence decreased from 9.3 to 5.4 
cases per 100,000 populations in the study period. 
However, the proportions of disease manifestations 
remained relatively stable: There was a 1.1% decrease 
in exclusively PTB, a 0.5% increase in both PTB and 
EPTB and a 0.6% increase in exclusively EPTB between 
2002 and 2009. 
Frequency of extrapulmonary 
tuberculosis forms 
When we used combined information on the main and 
secondary sites of disease rather than the main site 
only, overall EPTB affected sites increased by a factor 
of 1.5 (Table 1). The increases ranged from a factor of 
1.2 for extrathoracic LN (3,330 vs 4,129) to a factor of 
2.7 (192 vs 521) for disseminated TB.
Characteristics of extrapulmonary 
tuberculosis patients  
Overall, EPTB patients were similar to PTB patients in 
terms of median age and CFR (Table 2). However, they 
were more frequently female (49% (6,956/14,072) vs 
Table 1
Effect of taking in account the main and secondary sites of tuberculosis in identifying extrapulmonary tuberculosis, 
Germany, 2002–2009 (n=46,389 patients)
TB forms or TB sites
Total TB sites according to 
the main site of disease 
notifieda 
(N=46,321)b
Total TB sites resulting 
from the main and 
secondary sites of disease 
notified (N=51,232)c
Increase of EPTB sites 
resulting from taking 
secondary sites into 
account (%)
Pulmonary 36,359 36,359 NA
Extrapulmonary 9,962 14,873 50
Extrathoracic lymph nodes 3,330 4,129 24
Pleura 1,579 2,806 78
Intrathoracic lymph nodes 1,130 1,812 60
Genitourinary 1,243 1,590 28
Bone and joints 610 835 37
Abdominal 455 750 65
Spine 373 544 46
Disseminated 192 521 171
Meninges 288 422 47
Central nervous system 64 116 81
Other forms 698 1,348 93
EPTB: extrapulmonary tuberculosis; NA: not applicable; TB: tuberculosis.
Up to two different TB disease sites per patient can be recorded. Lungs, when affected by TB, can only be recorded as the main site of 
disease. If two different EPTB sites are affected, the more severely affected is classified as main site of disease. If three or more sites are 
affected, the case is to classify as ‘disseminated’.
a  As there is one main site of disease per patient the total number of TB sites according to the main site notified, equals the number of 
patients.
b  28 of 46,349 patients included in the study did not have information on main site of disease. According to the rules of the notification 
system, these patients had only EPTB forms recorded as secondary sites.
C  As up to two sites per patient can be recorded (main and secondary site) the number of total TB sites resulting from considering the main 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































36% (13,165/36,324)) and more often foreign-born 
(51% (6,998/13,650) vs 42% (14,609/35,039)).
Across the individual extrapulmonary forms there were 
large differences in case characteristics. Genitourinary 
TB patients, for instance, were characterised by a 
high median age (61 years, IQR: 46–72) and only 32% 
(496/1,542) of foreign-born. 
The CFR was only 1% (45/4,076) in extrathoracic LN, 
but 27% (138/516) in disseminated TB. The median 
duration of hospitalisation was longest in meningitis 
and other CNS TB (36 days, IQR: 15–60 and 36 days, 
IQR: 19–52, respectively). 
Meningitis tuberculosis 
Meningitis TB was reported in 0.9% (422/46,349) 
of patients as main or secondary site, and in 0.6% 
(288/46,349) as the main site only. This manifestation 
was most frequent in children, affecting 3.9% (34/882) 
of those younger than five years old, 2.2% (10/460) of 
the five to nine year-olds, and 1.3% (5/388) of the 10 to 
14 year-olds. Though, only 0.8% (373/44,612) patients 
aged 15 years and above had meningitis, this age group 
accounted for 88% (373/422) of all meningitis patients. 
These proportions were stable from 2002 to 2009 in 
all age groups. Meningitis was more frequent among 
female than among male patients (1.1% (207/18,408) 
and 0.8% (215/27,896), respectively). 
The proportion of patients with meningitis varied by 
the region of origin, ranging from 0.5% (20/4,486) 
among patients born in the NIS, and 0.9% (227/25,051) 
among those born in Germany, to 2.0 % (35/1,787) 
among those born in the south-east Asia WHO region 
(Table 3).
In multivariable analysis, compared with non-menin-
gitis TB cases, patients with meningitis TB were more 
likely to be children younger than 5 years (OR: 4.90; 
95% CI: 3.40–7.07) and children between five and 
nine years-old (OR: 2.65; 95% CI: 1.40–5.00) (Table 
3). Female patients were more affected than males 
(OR: 1.42; 95% CI: 1.17–1.73). Meningitis TB patients 
were less likely to be born in the NIS (OR: 0.54; 95% 
CI: 0.34–0.85) than in Germany. There were no signifi-
cant differences for patients born in Turkey or in the 
Americas, the western Pacific, the remaining European 
and the African WHO regions. An origin of the south-
east Asia and the eastern Mediterranean region was 
significantly associated with meningitis (OR: 2.38; 
95% CI: 1.66–3.43; and OR: 1.51; 95% CI: 1.02–2.23, 
respectively). 
Being a new case as well as the examined pairwise 
interaction terms was not statistically significant in the 
multivariable model, nor did they contribute to improve 
the model fit. They were therefore excluded from the 
final model. 
Figure 2
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The CFR of meningitis TB patients was 25% (105/415) 
overall, but higher in adults than in patients younger 
than 15 years (27% (98/366) vs. 14% (7/49); Figure 2). 
In children, meningitis accounted for about half (7/13) 
of all illness-related deaths. 
Discussion
Our investigation of national TB surveillance data 
for EPTB between 2002 and 2009 indicated that in 
Germany analysing solely the main site of disease, as 
commonly done in surveillance, leads to overlooking 
one third of extrapulmonary manifestations reported 
as the secondary site. This applied to all individual 
EPTB manifestations including severe forms. European 
Centre for Disease Prevention and Control (ECDC) data 
indicate that, on average, about 6% of all TB patients in 
EU/EEA countries are reported with both PTB and EPTB 
[2]. This suggests that there could be similar increases 
in proportions of extrapulmonary forms, such as men-
ingitis, in other countries if both main and secondary 
site of diseases were considered.
Patients with any extrapulmonary manifestations were 
more often female and born abroad. This supports 
earlier findings [5,6,8,10,28,29] and may reflect dif-
ferences in TB pathogenesis related to sex [30] and 
ethnicity [8], as well as risk factor patterns varying by 
sex and region of origin [6-8,10]. Exceptions, such as 
the high proportion of genitourinary TB patients being 
born in Germany, are partly explained by the advanced 
patients’ age, in which the proportion of foreign-born 
individuals is small in Germany [31]. Such interactions 
across case characteristics underline the need for 
stratified and multivariable analyses, as we illustrated 
for meningitis TB. 
Overall 0.9% TB patients had meningitis, whereas only 
0.6% had been reported as main site of disease. Hence, 
re-classification increased the number of reported 
cases by a factor of 1.5. A similar proportion (0.5%) 
of meningitis TB was found in Germany from 1996 to 
2000, based on main site of disease only [28]. This 
stable proportion over time, in a context of a decrease 
in overall TB case numbers, suggests that there was 
neither a rise nor a particular progress in reducing this 
severe form. 
Children younger than five years were most affected 
by meningitis; representing 8% of all meningitis cases, 
though accounting for less than 2% of TB patients in 
Germany. This is in line with a 1970 to 2000 cohort 
study of CNS TB patients in Canada, reporting that 10% 
of CNS cases were younger than five years of age [32]. 
While meningitis was rare (0.8%) among TB patients 
who were 15 years and older, this age group accounted 
for 88% of all meningitis patients. A similar age dis-
tribution of meningitis cases was observed in a cohort 
study in Canada, whereby the age group older than 
15 years contributed to 82% of all meningitis patients 
[32]. A similar value of 76% was found for this age 
group in a retrospective analysis of notified meningitis 
cases in Denmark [19]. These countries have age struc-
tures comparable to Germany. Meningitis TB cases in 
adults may be an expression of age-specific risk fac-
tors including diabetes mellitus and immune compro-
mising conditions [19,21].
In multivariable analysis, meningitis TB remained 
independently associated with young age and being 
female, similar to findings from Canada [32], as well 
as specific regions of origin. The association of men-
ingitis with south-east Asia and eastern Mediterranean 
regions of origin is consistent with high proportions of 
all EPTB in patients born in these regions, and a low 
proportion in patients born in the NIS (data not shown). 
As to meningitis in particular, differences by region of 
origin might be shaped by the regions’ HIV prevalence, 
which is relatively high in the south-east Asia region 
[33], and different levels of BCG vaccination and differ-
ent BCG strains in use. BCG has been withdrawn based 
on risk-benefit assessments from the immunisation 
schedule since 1998 in Germany, in line with other low 
incidence countries [34,35], but remains endorsed and 
widely used elsewhere [36]. These findings need to be 
interpreted with care given that meningitis case num-
bers were small for some regions of origin, and that 
risk factor patterns may differ across countries within 
one WHO region. 
Meningitis was a severe EPTB form in terms of long-
est median hospital stay and case fatality. One quar-
ter of patients with meningitis died and the CFR was 
almost twice as high in adults as in children. Similarly, 
a long term mortality study on meningitis TB patients 
in Denmark, from 1972 to 2008, reported that patients 
aged between 16 and 60 years had a 2.68 times 
increased risk of death compared to children [14]. The 
observed 14% CFR in children is higher than those 
described by hospital-based studies in Spain (11%; 
N=28) and Argentina (7%; N=40) [17,18]. However, case 
inclusion criteria in those studies might have differed 
from surveillance data and case numbers were small. 
Our investigation was solely based on national routine 
TB surveillance data consisting of a legally defined 
variable set. 
The data source did not contain information on comor-
bidities associated with EPTB such as HIV/ acquired 
immunodeficiency syndrome (AIDS) or diabetes mel-
litus, on BCG vaccination status, on socio-behavioral 
factors including smoking and alcohol consumption, or 
treatment, precluding comprehensive risk factor analy-
ses for EPTB forms. 
Our study was subject to several limitations. First, 
data on hospitalisation were not complete as they do 
not belong to the surveillance key variables demanded 
and validated with high priority. A reporting bias, for 
instance, if longer hospitalisations were more fre-
quently known and documented, may exist. Second, 
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misclassification between meningitis and other CNS TB 
or differences in case ascertainment among physicians 
cannot be entirely ruled out. For this reason, we ran the 
multivariable analysis twice, first only with meningitis 
TB (as presented), and second merging meningitis with 
non-meningitis CNS TB cases as the outcome of inter-
est. The findings of both models did not vary markedly. 
Only the association with the WHO African region had 
additionally become significant.
Conclusion 
National TB surveillance data provide both, informa-
tion on occurrence of disease and its severity in terms 
of CFR and hospital stay. This information is needed 
to refine estimates of the Mycobacterium tuberculosis 
complex-related disease burden, currently restricted 
to pulmonary or pooled TB data [37], and to prioritise 
across different pathogen-related diseases within a 
country [38]. Site-specific analyses of EPTB forms, as 
shown for meningitis, help to target future research 
on risk factors, clinical outcome, diagnostic tools, and 
preventive and therapeutic options adapted to the indi-
vidual manifestations.
As to TB case management, knowledge of population 
groups most affected by extrapulmonary sites helps 
physicians to timely consider EPTB as differential diag-
nosis. This is important in low incidence countries with 
small patient numbers and risk of waning expertise. 
Given the frequent co-occurrence of pulmonary and 
extrapulmonary sites, routine screening for PTB among 
EPTB patients, and vice versa, is essential. 
Averting meningitis and other severe TB forms through 
timely contact tracing and preventive chemotherapy, in 
agreement with national recommendations [39], needs 
to be of high priority.
Altogether, EPTB manifestations, including often fatal 
meningitis, are more widespread in Germany than 
so far reflected by routine analyses. We thus recom-
mend to monitor severe disease more closely using 
all information on disease manifestation and severity 
generated by surveillance, and to transfer the gained 
knowledge to TB case management where awareness 
of EPTB is most important.
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